SEVEN RESEARCHERS HONORED FOR SCIENTIFIC ACHIEVEMENTS AND CONTRIBUTIONS TO THE DEMENTIA FIELD AT ALZHEIMER’S ASSOCIATION INTERNATIONAL CONFERENCE – QNT Press Release


SAN DIEGO, July 31, 2022 /PRNewswire/ — The Alzheimer’s Association® will present seven awards at the Alzheimer’s Association International Conference® (AAIC®) 2022, recognizing researchers for their varied expertise, noteworthy achievements and innovative contributions to the field of Alzheimer’s and dementia science.

“Our understanding of dementia science today owes much to these seven researchers and their collaborators,” said Maria C. CarrilloPh.D., chief science officer, Alzheimer’s Association. “The celebration of their accomplishments and their powerful work in diverse areas of study is an inspiration to all of us in the science community as we strive to end Alzheimer’s and all other dementia. “

AAIC Lifetime Achievement Awards

The AAIC Lifetime Achievement Awards are named in honor of Henry WisniewskiMD, Ph.D.; Khalid IqbalPh.D.; and Bengt WinbladMD, Ph.D., the co-founders of the International Conference on Alzheimer’s Disease, now known as the Alzheimer’s Association International Conference. These awards honor significant contributions to Alzheimer’s and dementia research, either through a single scientific discovery or a body of work.

Agneta NordbergMD, Ph.D., is the recipient of the Henry Wisniewski Lifetime Achievement Award. She is a professor of clinical neuroscience and director of the Nordberg Translational Molecular Imaging Lab at the Karolinska Institutetas well as a senior consultant in geriatric medicine at Karolinska University Hospital. Her research currently focuses on developing early diagnostic biomarkers and new drug targets in Alzheimer’s disease and other neurodegenerative disorders. Nordberg has contributed greatly to the field’s understanding of the neurotransmitter acetylcholine’s role in dementia, and has pioneered the use of brain amyloid positron emission tomography (PET) imaging to visualize abnormalities in tau protein and reactive astrogliosis.

Keith JohnsonMD, is the recipient of the Khalid Iqbal Lifetime Achievement Award. He is a professor at Harvard Medical Schoolthe director of molecular neuroimaging at Massachusetts General Hospital, and a neurologist at Brigham and Women’s Hospital. He is the co-principal investigator of the Harvard Aging Brain Study and leads the PET component of the Alzheimer’s Clinical Trials Consortium (ACTC). Johnson’s pioneering neuroimaging work has contributed greatly to the understanding of …

Full story available on Benzinga.com



Source link

Recommended For You

About the Author: News Center